Small Molecules

01 Feb 2007 Nexmed Announces Patient Dosing In Phase 3 Program For Anti-Fungal Product
31 Jan 2007 Exelixis Files IND Application for XL418
31 Jan 2007 First Subjects Dosed in Phase l Trial of Triple Action Agent Tyrima
31 Jan 2007 Debiopharm Signs R&D And Commercialisation Agreement With Kirin For The Development Of DEBIO-0719 In Oncology
31 Jan 2007 Immtech Completes Enrollment in Phase III Pivotal Trial of Pafuramidine for African Sleeping Sickness
31 Jan 2007 Innovative Long-Acting Contraceptive Product Mirena(R) approved in Japan
31 Jan 2007 Proton Pump Inhibitor Pariet(R) Tablets 10mg Receives Approval in Japan
31 Jan 2007 Lexicon Advances LX6171 for Cognitive Disorders into Phase 1b Clinical Trial
31 Jan 2007 Vistagen's AV-101 Drug Candidate Yields Positive Preclinical Data For Neuropathic Pain Applications
31 Jan 2007 YM Biosciences Announces Termination Of The Tesmilifene Phase III Pivotal Trial In Advanced Breast Cancer
31 Jan 2007 FDA approves Neuren's phase 3 Glypromate trial
31 Jan 2007 AVANIR Receives FDA Approvable Letter for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
31 Jan 2007 Santhera Updates Development Strategy for SNT-MC17/idebenone in Friedreich's Ataxia in the US
30 Jan 2007 Tarceva : European approval for pancreatic cancer treatment
30 Jan 2007 Sunesis Pharmaceuticals Reports Positive Initial Results From Phase 2 Small Cell Lung Cancer Trial With SNS-595
30 Jan 2007 Inflazyme Pharmaceuticals Announces Preliminary Outcome of the Phase 2b CAPSICS Asthma Trial
30 Jan 2007 Pharmion Corporation Announces FDA Approval of Vidaza NDA Supplement for IV Administration
30 Jan 2007 New indication for YAZ(R) approved in the U.S.
30 Jan 2007 Threshold Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Glufosfamide In Patients With Platinum-Resistant Ovarian Cancer
27 Jan 2007 Oral formulation of Fludara(R) approved in Japan
27 Jan 2007 Antiviral Agent Copegus(R) Tablet 200 mg Received Approval as a Combination Therapy with Chronic Hepatitis C Treatment Drug Pegasys
27 Jan 2007 Approval for Candin Antifungal Agent Funguard for Prophylaxis of Aspergillus and Candida infections in patients undergoing HSCT and Immunosuppressant Prograf for Lupus Nephritis in Japan
27 Jan 2007 AEterna Zentaris Discloses New In Vivo Data for ZEN-012 at the 7th Joint Conference of the AACR and JCA
26 Jan 2007 Biocryst Initiates Phase II Influenza Clinical Trial To Evaluate Peramivir
26 Jan 2007 European Medicines Agency Adopts Positive Opinion Recommending Approval of Xyrem(R) for the Treatment of Narcolepsy with Cataplexy in Adult Patients

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top